A HIV status-stratified analysis of Mpox risk factors among MSM in Mainland China over two years (2023-2024). [PDF]
Xiang H +5 more
europepmc +1 more source
TTV Viremia and Immune Responses Following Vaccination Against Mpox and Dengue Viruses. [PDF]
Minosse C +17 more
europepmc +1 more source
Mpox with painless anogenital and palmar lesions. [PDF]
Yoshida K, Ishiuchi T, Kutsuna S.
europepmc +1 more source
Mpox outbreak preparedness and response capacity in Nigeria's Federal Capital Territory: a mixed-methods study. [PDF]
Aribi T +7 more
europepmc +1 more source
Monkeypox (Mpox), a Resurging Global Public Health Concern: An Updated Outlook Through 2025. [PDF]
Islam DZ +13 more
europepmc +1 more source
Natural compounds of medicinal plants as a source for novel anti-orthopoxvirus medications. [PDF]
Makhlouf EA +3 more
europepmc +1 more source
Dynamics of Mpox epidemics by the interplay of COVID-19 pandemic in Africa. [PDF]
Oyedele OK +8 more
europepmc +1 more source
Risk Assessment Method for Global Monkeypox Importation into China - May 2022-September 2025. [PDF]
Shan S +12 more
europepmc +1 more source
Treatment of Severe Ocular Mpox with Cidofovir and Tecovirimat. [PDF]
Brousse X +8 more
europepmc +1 more source
Knowledge and attitudes toward mpox among the Lebanese population during the second wave and their attitudes toward vaccination. [PDF]
Tanashat M +10 more
europepmc +1 more source

